Skip to main navigation
Skip to search
Skip to main content
King's College London Home
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Datasets
Impacts
Prizes
Search by expertise, name or affiliation
Oier Ateka Ateka Barrutia
Dr
140
Citations
Overview
Fingerprint
Network
Research output
(2)
Similar Profiles
(1)
Fingerprint
Dive into the research topics where Oier Ateka Ateka Barrutia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
1
Similar Profiles
Antiphospholipid Syndrome
Medicine and Dentistry
100%
Antiphospholipid Antibody
Medicine and Dentistry
100%
Patient
Medicine and Dentistry
100%
Glycoprotein
Biochemistry, Genetics and Molecular Biology
100%
Chemoluminescence
Biochemistry, Genetics and Molecular Biology
100%
Titer
Biochemistry, Genetics and Molecular Biology
33%
Morbidity
Medicine and Dentistry
20%
Cross Sectional Study
Biochemistry, Genetics and Molecular Biology
16%
Research output
2
Article
Research output per year
Research output per year
Autoantibodies to domain 1 of beta 2 glycoprotein i determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome
Mahler, M.
,
Albesa, R.
,
Zohoury, N.
,
Bertolaccini, M. L.
,
Ateka-Barrutia, O.
,
Rodriguez-Garcia, J. L.
,
Norman, G. L.
&
Khamashta, M.
,
1 Jul 2016
,
In:
Lupus.
25
,
8
,
p. 911-916
6 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Glycoprotein
100%
Chemoluminescence
100%
Titer
33%
Cross Sectional Study
16%
40
Citations (Scopus)
Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS')
Rodriguez-Garcia, J. L.
,
Bertolaccini, M. L.
,
Cuadrado, M. J.
,
Sanna, G.
,
Ateka-Barrutia, O.
&
Khamashta, M. A.
,
Feb 2012
,
In:
Annals of the Rheumatic Diseases.
71
,
2
,
p. 242 - 244
3 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Patient
100%
Antiphospholipid Antibody
100%
Antiphospholipid Syndrome
100%
Morbidity
20%
Pregnancy
10%
100
Citations (Scopus)